Gainesville, Fla.-based University of Florida Health announced plans to construct a 240-bed specialty tower that will neuromedicine and cardiovascular services. The tower will include 18 operating ...

Please provide your email address to receive an email when new articles are posted on . A clinical-stage biotechnology company announced that it has raised $150 million in funding to advance its ...

University of Florida Health in Gainesville will open the UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital next month. In a news release, UF Health said the $415 million ...

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision ...

Today we officially welcome patients into the new UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital. This historic milestone for the University of Florida and UF Health ...

Neuromedicine services have launched at Highland Hospital in Rochester, N.Y., with the opening of a new unit that also expands the hospital’s joint center, according to a hospital news release. The ...

A DIFFERENT APPROACH: Asheville psychologist George Lindenfeld is trying to raise awareness of a device that uses auditory signals to treat post-traumatic stress disorder. Psychologist George ...

The Neuromedicine Pain Management Center at the University of Rochester (N.Y.) Medical Center’s department of neurosurgery has announced that it has been named a clinical care center of excellence for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ceretype Neuromedicine, a pioneer in the practical application and integration of functional MRI (fMRI), announced today that it has closed its second round of seed ...

Article ‘Count’ and ‘Share’ for Ceretype Neuromedicine based on listed parameters only. According to the parameters selected above, there are no articles from Ceretype Neuromedicine from 1 December ...

- Raymond Kelleher, M.D., Ph.D., of lead investor Cormorant Asset Management, and James Healy, M.D., Ph.D., of Sofinnova Investments, join Board of Directors BOSTON ...